argos therapeutics inc
(ARGS:Consolidated Issue listed on NASDAQ Global Market)
Mark T. Weedon MBA
|Age||Total Calculated Compensation||This person is connected to 20 board members in 1 different organizations across 3 different industries.|
See Board Relationships
Mr. Mark T. Weedon, MBA serves as a Principal of BWA Consulting, a business group. Mr. Weedon served as President and Chief Executive Officer of Argos Therapeutics, Inc. (Formerly MERIX Bioscience, Inc.). Mr. Weedon joined Argos Therapeutics, Inc., in January 2001. Mr. Weedon has over 25 years of experience in the pharmaceutical industry; most recently he was with Scriptgen (now Anadys) Pharmaceuticals as President and Chief Executive Officer. In the prior decade at ...
4233 Technology DrivePhone: 919-287-6300
Durham, North Carolina 27704
Board Members Memberships*
University of Toronto
The University Of Western Ontario
University of Western Ontario, Ivey School of Business
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Douglas J. Swirsky CPA, CFA||Chief Executive Officer, President, Corporate Secretary and Director|
|Kalevi Reijonen M.D.||Chief Executive Officer and President|
FIT Biotech Oy
|Hans Arwidsson Ph.D.||Chief Executive Officer and President|
Eurocine Vaccines AB
|Daniel J. O'Connor Esq.||Chief Executive Officer, President and Director|
|William D. Clark||Chief Executive Officer, President and Director|
Genocea Biosciences, Inc.
|$393.6K||Compensation as of Fiscal Year 2014.|